Survey of human papillomavirus types and their vertical transmission in pregnant women

BMC Infectious Diseases

Zhi-Qun Wang²  Ya-Li Hu²  Shu-Qin Li²  Ying Hong¹ 

[1] Nanjing University of Chinese Medicine, 210008, Nanjing, China;Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing 210008, China

关键词: Vertical transmission;    Pregnancy;    Human papillomavirus;   

Others  :  1171014
DOI  :  10.1186/1471-2334-13-109

 received in 2012-08-03, accepted in 2013-02-21,  发布年份 2013

【 摘 要 】

Background

The prevalence, genotypes, and vertical transmission characteristics of human papillomavirus (HPV) among pregnant women from Nanjing, China was investigated.

Methods

Cervical cells were collected from healthy pregnant women (n = 3139; stage of gestation, 24.6 ± 2.1 weeks) for cytological evaluation and determination of HPV infection status. Exfoliated oral and genital cells were collected from neonates (<1-day-old, n = 233) whose mothers were positive for HPV DNA. We used HPV Gene Chip technology with 23 HPV genotype probes to conduct our analysis.

Results

Overall prevalence of HPV DNA among pregnant women was 13.4% (422/3139). The most frequently detected HPV genotypes were HPV-16 (29.6%, 125/422), -18 (14.7%, 62/422), and -58 (14.2%, 60/422). The rate of concordance for HPV DNA in maternal-neonatal pairs was 23.6% (55/233), with HPV type-specific concordance occurring in 26 cases. A higher prevalence of HPV DNA was apparent in female neonates compared with males (17.7 vs. 11.6%).

Conclusions

The prevalence of cervical HPV DNA in pregnant women from Nanjing was low, with vertical transmission rates slightly higher. From our findings, we concluded that there was efficient vertical transmission of three HPV genotypes, with HPV-16 the most prevalent type in pregnant women and newborn babies.

【 授权许可】

   
2013 Hong et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Peng P, Weng X, Gu Z: Detection of the Asymptomatic Infection by Human Papillomavirus in Pregnant Women and Neonates. Chinese J Obste Gynecol 2000, 35:523-525. http://www.cnki.net/kcms/detail/detail.aspx?dbcode=cjfq&dbname=cjfq2000&filename=zhfc200009004&uid=&p= webcite
• [2]Sigurdsson K, Taddeo FJ, Benediktsdottir KR, Olafsdottir K, Sigvalda-son H, Oddsson K, Rafnar T: HPV genotypes in CIN 2-3 lesions and cervical cancer: a population-based study. Int J Cancer 2007, 121(12):2682-2687. PubMed PMID:17724723
• [3]Cates W Jr: Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis 1999, 26(4 Suppl):S2-S7. Review. PubMed PMID: 10227693
• [4]Jay N, Moscicki AB: Human papillomavirus infections in women with HIV disease: prevalence, risk, and management. AIDS Read 2000, 10(11):659-668. Review. PubMed PMID: 11186191
• [5]Smith EM, Parker MA, Rubenstein LM, Haugen TH, Hamsikova E, Turek LP: Evidence for vertical transmission of HPV from mothers to infants. Infect Dis Obstet Gynecol 2010, 2010:326369. Epub 2010 Mar 14. PubMed PMID: 20300545; PubMed Central PMCID: PMC2838362
• [6]Armbruster-Moraes E, Ioshimoto LM, Leão E, Zugaib M: Presence of human papillomavirus DNA in amniotic fluids of pregnant women with cervical lesions. Gynecol Oncol 1994, 54(2):152-158. PubMed PMID: 8063239
• [7]Frega A, Cenci M, Stentella P, Cipriano L, De Ioris A, Alderisio M, Vecchione A: Human papillomavirus in virgins and behaviour at risk. Cancer Lett 2003, 194(1):21-24. PubMed PMID: 12706855
• [8]Watts DH, Koutsky LA, Holmes KK, Goldman D, Kuypers J, Kiviat NB, Galloway DA: Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. Am J Obstet Gynecol 1998, 178(2):365-373. PubMed PMID: 9500501
• [9]de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX: Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007, 7(7):453-459. Review. PubMed PMID: 17597569
• [10]Lin H, Ma YY, Moh JS, Ou YC, Shen SY, ChangChien CC: High prevalence of genital human papillomavirus type 52 and 58 infection in women attending gynecologic practitioners in South Taiwan. Gynecol Oncol 2006, 101(1):40-45. Epub 2005 Oct 26. PubMed PMID: 16256180
• [11]Ye J, Cheng X, Chen X, Ye F, Lü W, Xie X: Prevalence and risk profile of cervical Human papillomavirus infection in Zhejiang Province, southeast China: a population-based study. Virol J 2010, 7:66. PubMed PMID: 20307327; PubMed Central PMCID: PMC2857835 BioMed Central Full Text
• [12]Medeiros LR, Ethur AB, Hilgert JB, Zanini RR, Berwanger O, Bozzetti MC, Mylius LC: Vertical transmission of the human papillomavirus: a systematic quantitative review. Cad Saude Publica 2005, 21(4):1006-1015. Epub 2005 Jul 11. Review. PubMed PMID: 16021238
• [13]LI SQ HONGY, WANG ZQ, HU YL: Screening and management of cervical cytopathology during pregnancy. Jiangsu Medical Journal 2011, 37(7):784-786. http://2010.cqvip.com/QK/93304X/201107/37571620.html webcite
• [14]Fife KH, Katz BP, Brizendine EJ, Brown DR: Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period. Am J Obstet Gynecol 1999, 180(5):1110-1114. PubMed PMID:10329863
• [15]Tenti P, Zappatore R, Migliora P, Spinillo A, Belloni C, Carnevali L: Perinatal transmission of human papillomavirus from gravidas with latent infections. Obstet Gynecol 1999, 93(4):475-479. PubMed PMID: 10214817
• [16]Mant C, Kell B, Rice P, Best JM, Bible JM, Cason J: Buccal exposure to human papillomavirus type 16 is a common yet transitory event of childhood. J Med Virol 2003, 71(4):593-598. PubMed PMID: 14556274
• [17]Smith EM, Ritchie JM, Yankowitz J, Swarnavel S, Wang D, Haugen TH, Turek LP: Human papillomavirus prevalence and types in newborns and parents: concordance and modes of transmission. Sex Transm Dis 2004, 31(1):57-62. PubMed PMID:14695959
• [18]Burchell AN, Winer RL, de Sanjosé S, Franco EL: Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006, 24(Suppl3 S3):52-61. Epub 2006 Jun 2. Review. PubMed PMID: 16950018
• [19]Garland SM, Ault KA, Gall SA, Paavonen J, Sings HL, Ciprero KL, Saah A, Marino D, Ryan D, Radley D, Zhou H, Haupt RM, Garner EI, Quadrivalent Human Papillomavirus Vaccine Phase III Investigators: Pregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6/11/16/18 vaccine: a combined analysis of five randomized controlled trials. Obstet Gynecol 2009, 114(6):1179-1188. PubMed PMID: 19935017
• [20]Wu X, Huang XH, Zhang WY: Fluid-based thin-layer method for screening of squamous intraepithelial lesions in pregnant women. Zhonghua Fu Chan Ke Za Zhi 2006, 41(10):689-692. Chinese. PubMed PMID: 17199925
• [21]Limaye A, Connor AJ, Huang X, Luff R: Comparative analysis of conventional Papanicolaou tests and a fluid-based thin-layer method. Arch Pathol Lab Med 2003, 127(2):200-204.
• [22]Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, Young N, Forum Group Members: The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002, 287(16):2114-2119. Review. PubMed PMID: 11966386
• [23]Chivukula M, Saad RS, Elishaev E, White S, Mauser N, Dabbs DJ: Introduction of the Thin Prep Imaging System (TIS): experience in a high volume academic practice. Cytojournal 2007, 4:6. PubMed PMID: 17288596; PubMed Central PMCID: PMC1802998 BioMed Central Full Text
• [24]Davey E, d'Assuncao J, Irwig L, Macaskill P, Chan SF, Richards A, Farnsworth A: Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prospective study. BMJ 2007, 335(7609):31. Epub 2007 Jun 29. PubMed PMID: 17604301; PubMed Central PMCID:PMC1910624
• [25]Meng X-Y, Tao M-F: Feasibility and result of routine screening for cervical disease during gestational period. J Tongji Univ (Medical Science) 2009, 30(3):103-105. http://lib.cqvip.com/qk/90060B/200903/30854473.html webcite
• [26]Wang X, Zhu Q, Rao H: Maternal-fetal transmission of human papillomavirus. Chin Med J (Engl) 1998, 111(8):726-727.
• [27]Tseng CJ, Lin CY, Wang RL, Chen LJ, Chang YL, Hsieh TT, Pao CC: Possible transplacental transmission of human papillomaviruses. Am J Obstet Gynecol 1992, 166(1 Pt 1):35-40.
• [28]Louie KS, de Sanjose S, Diaz M, Castellsagué X, Herrero R, Meijer CJ, Shah K, Franceschi S, Muñoz N, Bosch FX, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer 2009, 100(7):1191-1197. Epub 2009 Mar 10. PubMed PMID: 19277042; PubMed Central PMCID: PMC2670004
• [29]Kim CJ, Jeong JK, Park M, Park TS, Park TC, Namkoong SE, Park JS: HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions. Gynecol Oncol 2003, 89(2):210-217.
• [30]Li RZ, Shi JF, Zhou QZ, Wu RF, Li N, Wu LN, Zhou YQ, Wang Q, Liu ZH, Liu B, Qiao YL: Evaluation of gene chip technology for high risk type human papillomavirus in cervical cancer screening. Zhonghua Yi Xue Za Zhi 2006, 86(5):307-311. Chinese. PubMed PMID: 16677522
• [31]Halfon P, Benmoura D, Khiri H, Penaranda G, Blanc B, Riggio D, Sandri MT: Comparison of the clinical performance of carcinogenic HPV typing of the Linear Array and Papillocheck HPV-screening assay. J Clin Virol 2010, 47(1):38-42. Epub 2009 Nov 25. PubMed PMID: 19939732
• [32]Hong Y, Hu Y, Zhang L, Zhang C, Wang Z, Wu X, Zheng M, Xia Y, Gu Y: Research on the classification and maternal-fetal vertical transmission of human papilloma virus infection in gestational periods. Chin J Pract Gynecol Obstet 2008, 24(11):839-842. http://lib.cqvip.com/qk/90644A/200811/28636784.html webcite
• [33]Yu Y, Hong Y, Jin M, Song S, Hu Y, Wang Z, Shen R, Fang J, Wu X, Li J: A study on mother-to-child transmmission of HPV. Chin J Mat Child Health Res 2010, 21(3):316-319. http://lib.cqvip.com/qk/97998A/201003/34100204.html webcite
• [34]Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, Rozendaal L, Bezemer PD, Voorhorst FJ, Meijer CJ: High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum. Br J Cancer 2002, 87(1):75-80. PubMed PMID: 12085260; PubMed Central PMCID:PMC2364279
• [35]Qiao YL: Epidemiology of HPV infection and cervical cancer and perspective of HPV vaccination in Chinese women. Zhonghua Liu Xing Bing Xue Za Zhi 2007, 28(10):937-940. Chinese. PubMed PMID: 18399134
• [36]Wacholder S, Chen BE, Wilcox A, Macones G, Gonzalez P, Befano B, Hildesheim A, Rodríguez AC, Solomon D, Herrero R, Schiffman M, CVT group: Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials. BMJ 2010, 340:c712. PubMed PMID: 20197322; PubMed Central PMCID: PMC2831171
• [37]Zhang Y, Li Y, Gao Z: HR-HPV Infection in Pregnant or Postpartum Women. Chin J Nosocomiol 2009, 11(10):1199-1201. http://lib.cqvip.com/qk/98445X/200910/30351921.html webcite